Aspira Women's Health Inc. (AWHL) intrinsic value & 10-year financials
Aspira Women's Health Inc. (AWHL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 14.9% a year to $9.2M, with an average return on invested capital of 2471.6%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.23
- Market cap
- $7.8M
- Revenue (FY2025)
- $9.2M
- Revenue growth (10-yr CAGR)
- 14.9%
- ROIC (10-yr avg)
- 2471.6%
- Free cash flow (FY2025)
- -$7.0M
AWHL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $9.2M | -$12.8M | -$0.37 | -$7.0M | -85.9% | 320.3% |
| FY2024 | $9.2M | -$13.1M | -$0.93 | -$12.2M | -177.3% | 579.9% |
| FY2023 | $9.2M | -$16.7M | -$1.81 | -$15.9M | -205.9% | 511.6% |
| FY2022 | $8.2M | -$27.2M | -$0.23 | -$32.4M | -400.4% | 741.8% |
| FY2021 | $6.8M | -$31.7M | -$0.28 | -$27.6M | -478.5% | 1026.8% |
| FY2020 | $4.7M | -$17.9M | -$0.18 | -$15.2M | -386.6% | 879.9% |
| FY2019 | $4.5M | -$15.2M | -$0.18 | -$13.1M | -336.7% | 1280.1% |
| FY2018 | $3.1M | -$11.4M | -$0.16 | -$9.5M | -371.2% | 1899.9% |
| FY2017 | $3.1M | -$10.5M | -$0.20 | -$8.2M | -334.5% | 21527.8% |
| FY2016 | $2.6M | -$15.0M | -$0.29 | -$15.2M | -566.0% | -4052.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Aspira Women's Health Inc. is a consistent compounder, expanding top-line revenue at 14.9% annually over the past decade.
Aspira Women's Health Inc. has earned high returns on invested capital, averaging 24.7% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Over the decade, Aspira Women's Health Inc. shows that management has aggressively returned capital to shareholders by retiring 34.7% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Aspira Women's Health Inc. is modeled at 14.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-12.22 per share.